Bioprocessing

Biomanufacturing's Third Wave: Navigating New Complexities
Management & Regulatory Biomanufacturing's Third Wave: Navigating New Complexities

At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later